ArticleFrontiers in immunology2026

Adjuvant pegylated liposomal doxorubicin versus epirubicin sequential paclitaxel in triple-negative breast cancer: comparable efficacy with a distinct safety profile.

Shuanglong Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.